Patent classifications
A61K33/245
Ceramic glaze having antimicrobial property
An antimicrobial ceramic glazing composition contains one or more antimicrobial agents disposed therein. Methods for making and using the glazing composition are disclosed, as well as substrates having a fired antimicrobial glaze thereon. The antimicrobial agents comprise metallic oxides, with a subset of the disclosed combinations exhibiting synergistic effect in fired glazes.
Ceramic glaze having antimicrobial property
An antimicrobial ceramic glazing composition contains one or more antimicrobial agents disposed therein. Methods for making and using the glazing composition are disclosed, as well as substrates having a fired antimicrobial glaze thereon. The antimicrobial agents comprise metallic oxides, with a subset of the disclosed combinations exhibiting synergistic effect in fired glazes.
ANTIBACTERIAL BISMUTH COMPLEXES
Provided herein are organobismuth (III) phosphinate complexes, which comprise a phosphinate group and an aromatic carbocyclyl or aromatic heterocyclyl group. The complexes find use as antibacterial agents, and accordingly also provided herein are products, devices, compositions and materials comprising the complexes, for example medical products such as wound dressings and bandages.
Method based on bismuth ion for the treatment and prevention of a disease caused by a shiga toxin
The present invention relates to the a bismuth-based composition, particularly involving the use of bismuth ions, particularly the Bi.sup.+3 ion, for prevention and/or treatment of the haemolytic uremic syndrome, with the invention also relating to the use of a bismuth ion in the manufacture of a medicament for the prevention and/or treatment of an infection caused by a Shiga-toxin producing Escherichia coli strain, as well as to a method for preventing and/or treating the haemolytic uremic syndrome comprising administering bismuth ions to a patient in need thereof, and a method for inhibiting dissemination of the gene encoding virulence factors of a Shiga-toxin producing Escherichia coli strain in animals and humans.
MINERAL WATER COMPOSITION
A mineral water comprising a composition of a blend of minerals and trace rare earth elements is provided, the rare earth elements in the composition comprise Scandium, Yttrium, Lanthanum, Cerium, Praseodymium, Neodymium, Samarium, Europium, Gadolinium, Terbium, Dysprosium, Holmium, Erbium, Thulium, Ytterbium, Lutetium. The water is conducive to good health and can relieve the symptoms of some chronic diseases.
Bismuth(III) Compounds and Methods Thereof
The present disclosure relates to a pharmaceutical composition comprising: (a) -lactam antibiotics and (b) a metallo--lactamases (MBLs) inhibitor. The inhibitor relates to Bi(III) compounds or the pharmaceutically acceptable salts thereof. The present patent also provides methods of making Bi(III) compounds or the pharmaceutically acceptable salts thereof. Also provided is a method for treating MBLs-producing bacterial infection using a metal replacement mechanism.
Bismuth(III) Compounds and Methods Thereof
The present disclosure relates to a pharmaceutical composition comprising: (a) -lactam antibiotics and (b) a metallo--lactamases (MBLs) inhibitor. The inhibitor relates to Bi(III) compounds or the pharmaceutically acceptable salts thereof. The present patent also provides methods of making Bi(III) compounds or the pharmaceutically acceptable salts thereof. Also provided is a method for treating MBLs-producing bacterial infection using a metal replacement mechanism.
COMPOSITION COMPRISING ANTIMICROBIAL METAL IONS AND A QUATERNARY CATIONIC SURFACTANT
The present invention relates to an antimicrobial composition suitable for use on skin and wounds comprising a source of an antimicrobial metal ion and a quaternary cationic surfactant.
COMPOSITION COMPRISING ANTIMICROBIAL METAL IONS AND A QUATERNARY CATIONIC SURFACTANT
The present invention relates to an antimicrobial composition suitable for use on skin and wounds comprising a source of an antimicrobial metal ion and a quaternary cationic surfactant.
ANTIINFECTIVE FREE INTRAMAMMARY VETERINARY COMPOSITION
An antiinfective-free formulation for prophylactic treatment of mastitis in dry cows comprises a seal formulation having approximately 65% by weight of bismuth sub-nitrate in a gel based on aluminium stearate. The seal formulation is prepared by adding the bismuth sub-nitrate to the gel base in at least two separate stages.